AGWCA
BLFS

Annis Gardner Whiting Capital Advisors’s BioLife Solutions BLFS Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-377
Closed -$8.12K – 1221
2025
Q2 		$8.12K Buy
+377
New +$8.5K ﹤0.01% 772

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's BLFS Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 377 shares — an estimated $8.12K sold.

Annis Gardner Whiting Capital Advisors first reported a position in BLFS in Q2 2025 and held it in 1 quarter. The position peaked at $8.12K in Q2 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 377 BioLife Solutions shares in Q3 2025, an estimated $8.12K.
  • Annis Gardner Whiting Capital Advisors first reported a position in BioLife Solutions in Q2 2025 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's BioLife Solutions position peaked at $8.12K in Q2 2025.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.